22 May 2013
Keywords: encouraging, ph, data, avalon, avn944, usa, pharmaceuticals
Article | 22 December 2006
The USA's Avalon Pharmaceuticals says that Phase I study data on AVN944, its lead product candidate, for the treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2006
21 May 2013
© 2013 thepharmaletter.com